Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in TCRX — TScan Therapeutics, Inc.

CIK 1037389 NEW YORK, NY
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,300,263
-$78,167 QoQ
Shares Held
1,326,799
-2.8% QoQ
Ownership
1.96%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 60 holders
Holding Since
Mar 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. TCRX ranks #162 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in TCRX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,300,263 1,326,799
2026-03-31 $1,378,430 1,364,783
2025-12-31 $1,141,069 1,141,069
2025-09-30 $1,510,452 829,919
2025-06-30 $1,148,481 792,056
2025-03-31 $234,194 169,706
2024-12-31 $32,224 10,600
2024-09-30 $368,520 74,000
2024-06-30 $468,000 80,000
2024-03-31 $373,180 47,000
2023-12-31 $126,511 21,700
2023-09-30 $45,312 17,700
2023-06-30 $368,655 147,462
2023-03-31 $24,360 11,600
2022-12-31 $15,500 10,000
2022-03-31 $37,240 13,300